Prevention of dimethylsulfoxide-related nausea and vomiting by prophylactic administration of ondansetron for patients receiving autologous cryopreserved peripheral blood stem cells.

Publication Type:

Journal Article


Oncology nursing forum, Volume 40, Issue 3, p.285-92 (2013)


2013, Center-Authored Paper, Clinical Research Division, May 2013, Public Health Sciences Division, Research Trials Office Core Facility - Biostatistics Service


To evaluate the effectiveness of ondansetron for the prevention of nausea and vomiting from dimethylsulfoxide (DMSO) during autologous stem cell transplantation (ASCT) infusion.